Due to national shortage of the nebulization solutions, the formulary status of inhaler products has been temporarily adjusted to formulary, restricted to use during the albuterol/Duoneb shortage. Upon shortage resolution, these products will automatically return to their original formulary status. See Albuterol/Duoneb Shortage Mitigation for more information. (Updated Feb 2023)

For pediatrics, no automatic interchange in place. Use of this drug is generally discouraged by pediatric pulmonologists, contact physician to discuss use of possible alternatives. Patients may use their own supply.

Only stocking the 10-acutation (5-day) of the 2.5 mcg/actuation strength.

Reviewed: June 23, 2009, and 25 April 2017, April 28, 2020,

• Micromedex
• UpToDate
• Lippincott Advisor